Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
90.00
-1.31 (-1.43%)
Sep 10, 2026, 1:47 PM EDT - Market open

Hinge Health Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Revenue
720.06587.86390.4292.73
Revenue Growth
49.77%50.58%33.37%-
Gross Profit
608.75469.3300.59194.18
Operating Income
93.67-546.37-31.22-130.51
Net Income
107.29-424.09-11.93-108.14
Earnings Per Share
1.34-7.77-0.88-8.31
EPS Growth
----

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Cash & Investments
474.13477.03466.57423.36
Total Debt
5.898.0411.0715.73
Net Cash (Debt)
468.25469455.5407.62
Net Cash Growth
16.11%2.96%11.74%-
Net Cash Per Share
5.818.5933.6031.31

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
290.79171.4449-63.91
Capital Expenditures
-0.67-0.71-1.04-1.98
Free Cash Flow
290.12170.7347.96-65.89
Free Cash Flow Growth
218.23%255.97%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingJun '26 Dec '25 Dec '24 Dec '23
Gross Margin
84.54%79.83%77.00%66.33%
Operating Margin
13.01%-92.94%-8.00%-44.59%
Pretax Margin
15.41%-89.69%-2.88%-37.08%
Profit Margin
14.90%-72.14%-3.06%-36.94%
FCF Margin
40.29%29.04%12.29%-22.51%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Forward PE
34.6830.32--
P/FCF Ratio
25.0321.42--
PS Ratio
10.096.22--